Crinetics Pharmaceuticals
Price & Volume
Stats
See more52W Range | $25.83-$57.99 |
Market Cap | $3.7B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $18M |
Revenue Growth (YoY) | 2,873.4% |
Gross Profit (12 Mos) | -$339.1M |
Diluted EPS | -$5.14 |
News
See moreYahoo Finance • 4 days ago
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Yahoo Finance • 12 days ago
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
Yahoo Finance • 28 days ago
Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock
Yahoo Finance • last month
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
About
CEO | Dr. R. Scott Struthers Ph.D. |
Address | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 594 |